B iopharmaceutical manufacturing uses living cells to produce therapies that treat diseases like cancer, diabetes, and autoimmune disorders. Manufacturing medicine using biology presents different challenges from the traditional chemical manufacturing processes that stamp out identical pressed pills.

Biomanufacturing processes are hard to control...

Inside one of the new labs at the University of New Hampshire’s Manchester campus on a recent afternoon, assistant professor of biotechnology Kristen Johnson and two students evaluated genes as part of pancreatic cancer research.

The process is known as quantitative polymerase chain reaction, or qPCR.

“We are looking at various aspects of...

In my capacity as the Chair of the Council of the Manufacturing USA institute directors, I often get asked about trends in U.S. advanced manufacturing. When I receive a question like this, I try to think about advanced manufacturing as broadly as possible — and consider technologies that could stand to benefit most manufacturers, as well as the U.S...

The manufacturing process that takes the next big idea from concept to market is one of the greatest factors propelling innovation forward — or in some cases, holding it back. Without this important step, we’d live in a world without many of the ingenious technologies that improve our daily lives and excite our imaginations, from smartwatches to...

The world can’t stop talking about biopharma’s scientific achievements, but the discussion often avoids the industry’s biggest potential buzzkill: a shortage of properly trained workers to manufacture these new drugs.

There’s no denying that biopharma drugs will play a vital role in the future of medicine. Biologics make up about 40 percent of the...